Oncology is the medical specialty that deals with the diagnosis and treatment of cancer. Oncologists are medical doctors who are trained to treat cancer and provide care to patients with cancer. Oncologists also play a key role in cancer prevention, through activities such as screening for early detection of cancer and counseling patients on healthy lifestyle choices that can help reduce the risk of developing cancer.
That’s why New Day Diagnostics is constantly innovating and adding to our line of testing products:
However, current diagnostic testing performs poorly in the early stages of the disease, resulting in needless biopsies and higher healthcare costs.
Our non-invasive ProCare test leverages a novel biomarker for the detection of prostate cancer, hopefully allowing for earlier and more effective treatment.
Our test, Ovation, showed higher accuracy and specificity compared to the most commonly used test, which we hope will allow earlier diagnosis and improve the chance of survival for patients.
Here are some ways to reduce your risk of developing colon and ovarian cancers:
Get screened: Regular screening is important for early detection.
Eat a healthy diet: A diet rich in fruits, vegetables, and whole grains, and low in red and processed meats, can help reduce your risk of colon cancer.
Exercise regularly: Physical activity can help reduce your risk of colon cancer, as well as many other chronic diseases.
Avoid tobacco and limit alcohol consumption: Smoking and excessive alcohol consumption have been linked to an increased risk of colon cancer. If you smoke, quit, and try to limit your alcohol intake to no more than one drink per day for women and two drinks per day for men
CE Mark for Professional use.
This item is currently not available for sale in the USA until FDA authorized. This page is made available for informational purposes only.
*PPA = positive percent agreement
**NPA = negative percent agreement
†Ct values = cycle threshold value. The higher the Ct, the more PCR cycles it took to identify the presence of the antigen. This means that a higher Ct indicates lower viral loads.
- This product has been authorized by the FDA under an Emergency Use Authoization (EUA)
- This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
- The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.